A recent case study published in the journal Frontiers in Neuroscience describes an 80-year-old woman with advanced Alzheimer's disease who experienced temporary cognitive improvements after receiving a high dose of psilocybin from magic mushrooms. The patient, who had been under full-time care and typically communicated in single syllables, received a 5gm dose of Enigma strain mushrooms. Approximately 20 hours later, her speech and mobility improved significantly, allowing her to dress independently. Over the following days, enhancements included better emotional responsiveness, social interaction, and memory retrieval. Despite these improvements, researchers caution that the results should not be interpreted as a reversal of Alzheimer's pathology. Instead, they suggest that psilocybin may temporarily make latent cognitive capacities accessible. The study highlights the need for further systematic investigation into psilocybin's effects, particularly regarding its potential to modulate brain networks in patients with advanced dementia.